<H1>FDA Conducting Safety Review Of Weight Loss Drug</H1>

Review includes both prescription drug Xenical and OTC drug Alli

By James Limbach, ConsumerAffairs.com

The Food and Drug Administration (FDA) is reviewing adverse event reports of liver injury in patients taking the weight loss drugs Xenical and Alli, also known as orlistat.

Between 1999 and 2008, the FDA received 32 reports of serious liver injury in patients taking orlistat. Of those cases, 27 reported hospitalization and six resulted in liver failure. Thirty of the adverse events occurred outside the United States. The most commonly reported adverse events included yellowing of the skin or whites of the eyes (jaundice), weakness, and stomach pain.

ConsumerAffairs.com has received two reports of adverse effects of the drug.

FOR COMPLETE STORY, PLEASE CLICK HERE.



~Sandy G.